1. Home
  2. CRDF vs BCML Comparison

CRDF vs BCML Comparison

Compare CRDF & BCML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cardiff Oncology Inc.

CRDF

Cardiff Oncology Inc.

HOLD

Current Price

$1.58

Market Cap

130.7M

Sector

Health Care

ML Signal

HOLD

Logo BayCom Corp

BCML

BayCom Corp

HOLD

Current Price

$29.73

Market Cap

317.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRDF
BCML
Founded
1999
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
130.7M
317.2M
IPO Year
2012
2018

Fundamental Metrics

Financial Performance
Metric
CRDF
BCML
Price
$1.58
$29.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$9.63
$34.00
AVG Volume (30 Days)
552.3K
17.0K
Earning Date
05-07-2026
04-23-2026
Dividend Yield
N/A
4.05%
EPS Growth
27.37
3.81
EPS
N/A
2.18
Revenue
$365,993.00
N/A
Revenue This Year
N/A
$13.71
Revenue Next Year
N/A
$5.25
P/E Ratio
N/A
$13.58
Revenue Growth
49.61
N/A
52 Week Low
$1.48
$22.22
52 Week High
$4.56
$33.15

Technical Indicators

Market Signals
Indicator
CRDF
BCML
Relative Strength Index (RSI) 35.65 55.90
Support Level $1.51 $29.17
Resistance Level $1.68 $30.61
Average True Range (ATR) 0.09 0.74
MACD -0.02 0.12
Stochastic Oscillator 7.87 76.59

Price Performance

Historical Comparison
CRDF
BCML

About CRDF Cardiff Oncology Inc.

Cardiff Oncology Inc is a clinical-stage biotechnology company that leverages PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies for various cancers with unmet medical needs. The company focuses on targeting tumor vulnerabilities with treatment combinations of onvansertib, its oral and selective PLK1 inhibitor, and standard-of-care (SoC) therapeutics. The firm's clinical program pipeline focuses on indications such as RAS-mutated metastatic colorectal cancer (mCRC), investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma (mPDAC), small cell lung cancer (SCLC), metastatic triple negative breast cancer (mTNBC), and Chronic Myelomonocytic Leukemia (CMML). Geographically, it operates only in the United States.

About BCML BayCom Corp

BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses, and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services. The Company operates as one reportable segment: banking operations.

Share on Social Networks: